financetom
Business
financetom
/
Business
/
Walt Disney Poised to Post Double-Digit EPS Growth in Fiscal Q3, UBS Says
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Walt Disney Poised to Post Double-Digit EPS Growth in Fiscal Q3, UBS Says
Jul 16, 2025 8:15 AM

10:45 AM EDT, 07/16/2025 (MT Newswires) -- Walt Disney Company ( DIS ) is likely to post double-digit earnings growth in fiscal Q3 on the back of strong demand at parks and improvement in direct-to-consumer segment profitability, UBS said in a Tuesday research note.

The brokerage modeled Q3 EPS of $1.59, a 13% rise from a year earlier, on revenue of $23.3 billion. For full-year 2025, analysts expect EPS of $5.89, according to the note.

UBS said it expects 4.8% revenue growth in Q3 for the experiences segment and earnings before interest and taxes for parks to rise 15% from a year earlier. Sports revenue is expected at $4.3 billion.

For Disney+, UBS expects a 1.6 million increase in subscribers during Q3 and a 6.7% DTC segment revenue growth. The company is on track to generate over $1 billion in DTC segment EBIT in 2025 despite higher tech and content spend, analysts wrote.

"We remain constructive on the outlook for F26 given underlying trends at the parks, new cruise capacity, strong content pipeline and inflecting margins in DTC with upside from full control of Hulu," UBS noted.

The brokerage said it reiterated its buy rating on the stock and boosted its price target to $138 per share from $120.

Price: 120.21, Change: +1.22, Percent Change: +1.03

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
IceCure Gets Notice of Allowance from China's Intellectual Property Regulator
IceCure Gets Notice of Allowance from China's Intellectual Property Regulator
Mar 17, 2025
09:06 AM EDT, 03/17/2025 (MT Newswires) -- IceCure Medical ( ICCM ) said Monday that it has received a notice of allowance from the China National Intellectual Property Administration for its cryogenic system connector invention. The notice follows grants for the same patent in the US, Europe, and Japan, the company said. The company said its novel cryogenic pump is...
Oil Rises on U.S. Strikes in Yemen and China Growth Prospects
Oil Rises on U.S. Strikes in Yemen and China Growth Prospects
Mar 17, 2025
09:07 AM EDT, 03/17/2025 (MT Newswires) -- Oil prices moved higher early on Monday after the United States launched attacks on Yemen's Iran-backed Houthi militants, a response to the group's attacks on Israel and Red Sea shipping, while China said it plans moves to boost consumer spending. West Texas Intermediate crude oil for April delivery was last seen up US$0.85...
Market Chatter: HSBC Said to Discuss Sale of $8.3 Billion of Australian Home Loans
Market Chatter: HSBC Said to Discuss Sale of $8.3 Billion of Australian Home Loans
Mar 17, 2025
09:02 AM EDT, 03/17/2025 (MT Newswires) -- HSBC Holdings ( HSBC ) is in talks to sell about A$13 billion ($8.3 billion) of Australian home loans, Bloomberg reported Monday, citing people familiar with the matter. HSBC ( HSBC ) did not immediately reply to a request for comment from MT Newswires. (Market Chatter news is derived from conversations with market...
Vtv Therapeutics Says FDA Lifts Clinical Hold on Cadisegliatin Program for Diabetes; Shares Up Pre-Bell
Vtv Therapeutics Says FDA Lifts Clinical Hold on Cadisegliatin Program for Diabetes; Shares Up Pre-Bell
Mar 17, 2025
09:05 AM EDT, 03/17/2025 (MT Newswires) -- Vtv Therapeutics ( VTVT ) said Monday that the US Food and Drug Administration has lifted a clinical hold on its cadisegliatin clinical program, including a phase 3 trial in type 1 diabetes. The company said it plans to resume the trial after submitting a protocol amendment to reduce its duration from 12...
Copyright 2023-2026 - www.financetom.com All Rights Reserved